Molecular findings in oral premalignant fields: update on their diagnostic and clinical implications
- 18 August 2011
- journal article
- review article
- Published by Wiley in Oral Diseases
- Vol. 18 (1) , 40-47
Abstract
The development of multiple oral tumours, seen in up to 30% of patients with a primary oral squamous cell carcinoma, is sometimes attributable to the presence of genetically altered premalignant fields and has important prognostic implications. Molecular techniques available for the definitive diagnosis of such a field (loss of heterozygosity analysis of 3p, 9p and 17p and study of TP53 tumour suppressor gene mutation) are expensive, complex and not universally available, hampering their routine application. Nevertheless, molecular diagnosis is essential for modern assessment of the risk of multiple tumours and for decisions on the appropriate preventive and therapeutic approaches. This article reviews current knowledge on molecular findings in premalignant fields in the oral cavity and oropharynx and provides an update on criteria for their identification, discussing the clinical and therapeutic implications.Keywords
This publication has 77 references indexed in Scilit:
- Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinomaBritish Journal of Cancer, 2010
- Proliferative verrucous leukoplakia: a concise updateOral Diseases, 2010
- Field cancerization in oral lichen planusEuropean Journal of Surgical Oncology, 2007
- Progress in Chemoprevention Drug Development: The Promise of Molecular Biomarkers for Prevention of Intraepithelial Neoplasia and Cancer—A Plan to Move ForwardClinical Cancer Research, 2006
- A noninvasive genetic screening test to detect oral preneoplastic lesionsLaboratory Investigation, 2005
- Oral erythroplakia—a reviewOral Oncology, 2005
- Oral Lichen Planus and Its Association With Squamous Cell Carcinoma: An Update on Pathogenesis and Treatment ImplicationsThe Laryngoscope, 1996
- The p53-mdm-2 autoregulatory feedback loop.Genes & Development, 1993
- Fenretinide (4-HPR) in chemoprevention of oral leukoplakiaJournal of Cellular Biochemistry, 1993
- 13-cis-Retinoic Acid in the Treatment of Oral LeukoplakiaNew England Journal of Medicine, 1986